Skip to main content
Top menu
Cochrane Library
Cochrane.org
Tweet us
Admin
Cochrane
Infectious Diseases
Trusted evidence.
Informed decisions.
Better health.
NOTE
: the CIDG editorial base closed permanently on Thurs 19 Dec 2024.
Read our
2024 CIDG end of year and programme message
.
News
What's new! CIDG Publications March 2021
1 Apr 2021
The story of hydroxychloroquine and COVID-19: new Cochrane editorial
A new Cochrane editorial examines the 2020 story of chloroquine or hydroxychloroquine for treating COVID-19. Read the full Cochrane editorial here.
26 Mar 2021
Update (24 Mar 2021) Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection
How accurate are rapid tests for diagnosing COVID‐19?
24 Mar 2021
Special Collection: diagnosing tuberculosis
The Cochrane Library releases an updated
23 Mar 2021
New: Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?Why is using Xpert tests to screen for pulmonary tuberculosis important?
23 Mar 2021
Update (16 Mar 2021) Thoracic imaging tests for the diagnosis of COVID‐19
Original version published on 30 September 2020.This is the second update of this review. The review authors included studies in people with suspected COVID-19 only, and excluded studies in people with confirmed COVID-19. The evidence is up to date to 30 September 2020.
17 Mar 2021
What's new! CIDG Publications May 2021
During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews.
7 Mar 2021
What's new! CIDG Publications February 2021
One new COVID-19 review, one updated COVID-19 review, and one updated Cochrane review are in Issue 2, 2021 of the Cochrane Database of Systematic Reviews.
3 Mar 2021
Update: Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19
23 Feb 2021
Update: Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis
Why is improving the diagnosis of pulmonary tuberculosis important?
23 Feb 2021
Pagination
First page
« First
Previous page
‹‹
…
Page
8
Page
9
Page
10
Page
11
Current page
12
Page
13
Page
14
Page
15
Page
16
…
Next page
››
Last page
Last »
Main navigation
About CIDG
Evidence & Policy
Resources
News
Contact us
Join Cochrane